16-5072040-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM2
The NM_019109.5(ALG1):c.191C>T(p.Thr64Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000139 in 1,436,550 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T64N) has been classified as Likely benign.
Frequency
Consequence
NM_019109.5 missense
Scores
Clinical Significance
Conservation
Publications
- ALG1-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALG1 | NM_019109.5 | c.191C>T | p.Thr64Ile | missense_variant | Exon 1 of 13 | ENST00000262374.10 | NP_061982.3 | |
| ALG1 | NM_001438123.1 | c.191C>T | p.Thr64Ile | missense_variant | Exon 1 of 12 | NP_001425052.1 | ||
| ALG1 | XR_007064892.1 | n.198C>T | non_coding_transcript_exon_variant | Exon 1 of 10 | ||||
| ALG1 | NM_001330504.2 | c.-389C>T | upstream_gene_variant | NP_001317433.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00 AC: 0AN: 198180 AF XY: 0.00
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1436550Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 712360 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
ALG1-congenital disorder of glycosylation Uncertain:1
This sequence change replaces threonine with isoleucine at codon 64 of the ALG1 protein (p.Thr64Ile). The threonine residue is moderately conserved and there is a moderate physicochemical difference between threonine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ALG1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALG1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at